- Home
- LSPD vs VERA Comparison
LSPD vs VERA Comparison
Compare LSPD & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSPD
- VERA
- Stock Information
- Founded
- LSPD 2005
- VERA 2016
- Country
- LSPD Canada
- VERA United States
- Employees
- LSPD N/A
- VERA N/A
- Industry
- LSPD
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- LSPD
- VERA Health Care
- Exchange
- LSPD Nasdaq
- VERA Nasdaq
- Market Cap
- LSPD 1.6B
- VERA 2.0B
- IPO Year
- LSPD 2020
- VERA 2021
- Fundamental
- Price
- LSPD $11.65
- VERA $23.65
- Analyst Decision
- LSPD Buy
- VERA Buy
- Analyst Count
- LSPD 13
- VERA 8
- Target Price
- LSPD $13.42
- VERA $64.63
- AVG Volume (30 Days)
- LSPD 740.9K
- VERA 2.3M
- Earning Date
- LSPD 07-31-2025
- VERA 08-07-2025
- Dividend Yield
- LSPD N/A
- VERA N/A
- EPS Growth
- LSPD N/A
- VERA N/A
- EPS
- LSPD N/A
- VERA N/A
- Revenue
- LSPD $1,076,826,000.00
- VERA N/A
- Revenue This Year
- LSPD $13.02
- VERA N/A
- Revenue Next Year
- LSPD $16.19
- VERA N/A
- P/E Ratio
- LSPD N/A
- VERA N/A
- Revenue Growth
- LSPD 18.43
- VERA N/A
- 52 Week Low
- LSPD $7.34
- VERA $18.53
- 52 Week High
- LSPD $18.96
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- LSPD 56.53
- VERA 53.02
- Support Level
- LSPD $11.20
- VERA $22.28
- Resistance Level
- LSPD $11.79
- VERA $23.97
- Average True Range (ATR)
- LSPD 0.39
- VERA 1.21
- MACD
- LSPD -0.01
- VERA 0.11
- Stochastic Oscillator
- LSPD 68.77
- VERA 66.53
About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, United Kingdom, Australia, and other countries. It derives a majority of its revenue from the United States.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.